Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. 1994

H H Balfour, and C Benson, and J Braun, and B Cassens, and A Erice, and A Friedman-Kien, and T Klein, and B Polsky, and S Safrin
Department of Laboratory Medicine & Pathology, University of Minnesota Health Sciences Center, Minneapolis.

Persons with AIDS who have CD4+ counts < or = 100 and transplant patients, especially bone marrow allograft recipients, may experience clinically significant infections with acyclovir-resistant herpes simplex virus (HSV) or varicella-zoster virus (VZV). Patients who have received prior repeated acyclovir treatment appear to be at the highest risk of harboring acyclovir-resistant strains. Algorithms for the management of these infections were developed at a recent roundtable symposium. The consensus of the panelists was that treatment with foscarnet should be initiated within 7-10 days in patients suspected to have acyclovir-resistant HSV or VZV infections. Foscarnet therapy should be continued for at least 10 days or until lesions are completely healed.

UI MeSH Term Description Entries
D008297 Male Males
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006562 Herpes Zoster An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) Shingles,Zona,Zoster
D006566 Herpesviridae Infections Virus diseases caused by the HERPESVIRIDAE. Herpesvirus Infections,B Virus Infection,Infections, Herpesviridae,Infections, Herpesvirus,B Virus Infections,Herpesviridae Infection,Herpesvirus Infection,Infection, B Virus,Infection, Herpesviridae,Infection, Herpesvirus,Infections, B Virus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U

Related Publications

H H Balfour, and C Benson, and J Braun, and B Cassens, and A Erice, and A Friedman-Kien, and T Klein, and B Polsky, and S Safrin
January 1996, Advances in experimental medicine and biology,
H H Balfour, and C Benson, and J Braun, and B Cassens, and A Erice, and A Friedman-Kien, and T Klein, and B Polsky, and S Safrin
March 1997, The Western journal of medicine,
H H Balfour, and C Benson, and J Braun, and B Cassens, and A Erice, and A Friedman-Kien, and T Klein, and B Polsky, and S Safrin
October 2003, Therapeutische Umschau. Revue therapeutique,
H H Balfour, and C Benson, and J Braun, and B Cassens, and A Erice, and A Friedman-Kien, and T Klein, and B Polsky, and S Safrin
January 1992, Heart & lung : the journal of critical care,
H H Balfour, and C Benson, and J Braun, and B Cassens, and A Erice, and A Friedman-Kien, and T Klein, and B Polsky, and S Safrin
October 2022, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
H H Balfour, and C Benson, and J Braun, and B Cassens, and A Erice, and A Friedman-Kien, and T Klein, and B Polsky, and S Safrin
September 2002, The Medical journal of Australia,
H H Balfour, and C Benson, and J Braun, and B Cassens, and A Erice, and A Friedman-Kien, and T Klein, and B Polsky, and S Safrin
June 1988, Infectious disease clinics of North America,
H H Balfour, and C Benson, and J Braun, and B Cassens, and A Erice, and A Friedman-Kien, and T Klein, and B Polsky, and S Safrin
April 2003, Dermatologic clinics,
H H Balfour, and C Benson, and J Braun, and B Cassens, and A Erice, and A Friedman-Kien, and T Klein, and B Polsky, and S Safrin
June 2012, Journal of the American Academy of Dermatology,
H H Balfour, and C Benson, and J Braun, and B Cassens, and A Erice, and A Friedman-Kien, and T Klein, and B Polsky, and S Safrin
September 1992, Seminars in dermatology,
Copied contents to your clipboard!